chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a 61 year old female patient concerning herself. The patient did not have pertinent medical history and drug reaction/allergies. The patient had concomitant medications, but she refused to answer the name of medications. In around February 2016, the patient was vaccinated with ZOSTAVAX (strength, dose, frequency, lot# and expiration date were unknown) (route reported "vaccine") for "prevent the shingles". On 12-JAN-2017(reported as 8 days ago), the patient experienced a mild case of the shingles. The treatment was given for the shingles. The outcome of the event and the causality between ZOSTAVAX and the event were unknown. Additional information is not expected since there was no consent to contact the physician.
stated that he was diagnosed with myocarditis; stated that he is weak; This is a spontaneous report from a contactable consumer. The report from a 25-year-old male patient received bnt162b2 (Pfizer Covid 19 vaccine), single dose via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 for covid-19 immunization. The patient experienced stated that he was diagnosed with myocarditis (hospitalization) on an unspecified date with outcome of unknown, stated that he is weak on an unspecified date with outcome of unknown. Dates when patient was in hospital for stated that he was diagnosed with myocarditis was Unspecified. Caller stated that they wanted information. Stated that patient was hospitalized after the second administration of Pfizer vaccine. Stated that he was diagnosed with myocarditis. Wanted to know if there was any support for men diagnosed with that. Stated that it was quite expensive and confusing. Is for the Pfizer Covid 19 vaccine. Stated that he was weak. Stated that he was just released yesterday.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
pt was vaccinated, waited for 15 minutes and left, then she came back in 10 min complaining of swelling in her fingers and hand of vaccintated arm.  she sat at the pharmacy for 30-45 minutes and was given a ice bag and noted that was a bit better and will leave
Pt recv vax & exp lack of seroconversion, vomiting & low grade fever.
Information has been received from a physician concerning a 11 year old male who on 14-AUG-2007 was vaccinated with varicella virus vaccine live (Oka/Merck) (656922/0450U). In approximately August 2007, the patient experienced a nodule, local injection site pain and local injection site swelling. He sought unspecified medical attention. Subsequently, the patient recovered from a nodule, local injection site pain and local injection site swelling. Additional information has been requested.
Painful injection; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 22K-163-4383471-00.  A 72-year-old female patient received BNT162b2 (BNT162B2), on 01Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 72 years intramuscular for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot number: unknown; Route of administration: intramuscular), administration date: 06Mar2021, when the patient was 71-year-old, for Covid-19 immunisation, reaction(s): "fatigue", "Chills"; BNT162b2 (DOSE 2, SINGLE, Lot number: unknown; Route of administration: intramuscular), administration date: 27Mar2021, when the patient was 71-year-old, for Covid-19 immunisation. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Painful injection".  Additional information: It was also reported that it was unknown if patient was enrolled in a Covid-19 Vaccine Trial. Causality as per reporter for event vaccination site pain was possible.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reporter's Comments: Non-serious spontaneous case routed to Distribution.
The next day I was feeling fatigue. My arm was sore & I had headaches. I did talk to a clinic virtually for my headaches.
I tested positive for COVID-19. I was achy, chilly, cold for hours, had a headache, congestion, sneezing, coughing, tightness, ear pain, fever, and a sore throat. I had bad tachycardia all night long. My lungs were cramping. I had lung pain and wheezing. My heart rate was high. I felt nauseated with no appetite and dehydrated. I had sinus pain and a headache. For a few days my taste was weird then I din have any taste or smell. I felt weak. I had heart complications and muscle spasms. I had a very dry mouth. I had a very heavy period. I was coughing badly. I had abdominal pain and hot flashes and fatigue. Toward the end my heart rate started to get low, and my oxygen was dropping. My migraines and breathing have gotten worse. When my heart rate started going to slow, I had to have some of my medication changed because of that. I went to the ER for extreme fatigue, dehydration, and because of my breathing. My stomach has also felt bad. It has been 20 days since it started.
Dizziness, pain, lightheaded, sweating within 30 seconds, lasting 15 minutes. After 5 hours, new symptoms, lasting for 3 days, headache, chills, muscle aches, swollen lymph nodes, fever, fatigue.
developed itchy papular rash on arms which spread to neck 3 days later.  Improved with taking hydroxyzine, and claritin. denies shortness of breath fevers, chills
started ovulating and having periods again; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series completed but manufacturer unknown), for covid 19 immunization. The following information was reported: OVULATION DISORDER (non-serious), outcome "unknown", described as "started ovulating and having periods again".  Additional information: After receiving 3rd COVID 19 vaccine the patient's reproductive system had gone into reverse. She had not experienced a period for almost a year. But since receiving 3rd vaccine she had started ovulating and having periods again. It was also reported that she know of 2 other women of her age who had also experienced similar events.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Pt recvd 1st dose Hep B vax 6FEB92 & 15FEB92 devel t103, abd pain; 17FEB92 to ER & hospitalized w/diverticulitis; 17FEB92 lab eval revealed WBC 10,000 w/ 76% polys, liver funct tests & serum amylase were neg; ultrasound pos for leiomyomata;
This spontaneous report was received from a Registered Nurse refers to a 17 year old patient of an unknown gender. The patient's pertinent medical history, concurrent conditions and drug reactions/allergies were not provided. On 22-MAR-2018, the patient was vaccinated with improperly stored GARDASIL 9, lot # N017686 (expiry date: 02-FEB-2020) for prophylaxis (incorrect product storage) (dose not reported). The vaccine was concomitantly reconstituted with properly stored sterile diluent (MERCK STERILE DILUENT). The vaccine underwent a temperature excursion of 35.30 F for 0.25 hours. No adverse effects were reported. The call was because of a data logger. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1804USA000815: US-009507513-1809USA002916: US-009507513-1809USA002917: US-009507513-1809USA002918: US-009507513-1809USA002919: US-009507513-1809USA002920: US-009507513-1809USA002922: US-009507513-1809USA002923:
Vaccine administration error.  It is suspected that a 1/2 inch needle syringe was used instead of a IM 1 inch needle syringe.
I noticed in May of 2021 that my period was very light and started 4 days later. It stayed that way and at times I missed my cycle all together. It has remained irregular and unpredictable. I spoke with her in August 2022. The doctor indicated that it could be a product of age as well.
Started with chills and fever of 105 around 1:30 AM. Headache and aching joints started about an hour later. Tried to take Tylenol but vomited it right back up. High fever continued until approximately 8:30 PM on 4/14/2021. Headache continued throughout night of 4/14/2021 and day of 4/15/2021. Unable to eat due to nausea. Headache finally eased up around 11:00 PM 4/15/2021. Still unable to eat but really thirsty. As of 11:00 PM 4/15/2021 still experiencing stiff neck and low grade fever.
Patient was extremely nervous about the vaccine. He immediately started to feel tingling/numbness of the RA, following a localized rash at the injection site. After 15 minutes the rash subsided and patient states he is feeling nauseous and still having numbness.
Hurt right away got worse at site. Got tired that evening. Next day 6-12-18 achy all over, headache. Blood pressure up 30 points, heart rate up 20 points. Resolved 6-13-18.
she doesn't feel good at all; terrible headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (she doesn't feel good at all) and HEADACHE (terrible headache) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (she doesn't feel good at all) and HEADACHE (terrible headache). At the time of the report, MALAISE (she doesn't feel good at all) and HEADACHE (terrible headache) outcome was unknown.            Concomitant product was not provided  Treatment information was not provided
CHF exacerbation with new a fib/flutter, and AKI, elevated troponin,aspiration pneumonia, lactic acidosis
Patient reporting experiencing metallic taste mouth , unusual tiredness and feeling faint upon standing starting day after receiving vaccines to present day
After getting vaccination, I got a cart and rome around with a cart to get groceries. So just like with all the other covid vaccine, I did not feel bad. I was sitting on sofa, first I started feeling achy with a little bit of a headache, within 30 mins, my teeth were chattering. I felt nauseous, I made it in the bathroom, and it was a 100.2 which is what it is now, so I got the Tylenol, then went to eat, so I could have something on my stomach. I coated my stomach, I literally let the Tylenol melt on my tongue. I called a friend of mine, and asked her to talk to me so I don't feel as bad, so when i turned to have a cup to drink, i had vertigo. My teeth was chattering, and she stayed on the phone with me for 30 mins. The Tylenol took maybe 30 mins so I could stop the chattering, I still had aching with the vertigo type. And umm, I didn't go to bed until 2:00. I woke up this morning, to get something to drink and use the bathroom, and still had a temperature, when back to bed. Last night i called my doctor to ask why am I having symptoms, and no one answer the phones any more.
3-4 out of 10 headache immediately following the vaccine, persisted for over 2 weeks, pt came to ED with 10 out of 10 headache at 2.5 weeks.  all head imagine was negative, including MRI.  pt never gets headaches.  presumed to be migraine
patient normal has resting heart rate of 60bpm patient stated his heart rate after beginning a while after vaccination was 90 to 120 bpm and patient reported that rate continued to time of calling pharmacy around 10am the next day.  patient reported otherwise feeling fine with no other issues. Patient was advised to monitor pulse and follow up with primary doctor. patient did mention noticing a similar elevated pulse after his second dose that resolved on its own but not after his first dose.
There was not an adverse reaction but am reporting that this dose was given from a vial beyond the recommended 31 days refrigeration.
SWELLING IN THROAT, SWELLING IN INJECTION SITE DOWN TO WRIST, MIGRAINE, DIZZINESS,  EXHAUSTION, COLD SWEATS
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 61-year-old female patient received BNT162b2 (BNT162B2), as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 2, SINGLE, Each one made me so sick I missed five days of work each time I got the shot.), for COVID-19 Immunization, reaction(s): "Sick"; Bnt162b2 (DOSE 1, SINGLE, Each one made me so sick I missed five days of work each time I got the shot.), for COVID-19 Immunization, reaction(s): "Sick". The following information was reported: BLISTER (non-serious), outcome "unknown", described as "The last one (booster) put the huge blister on my arm"; ILLNESS (non-serious), outcome "unknown", described as "Each one made me so sick I missed five days of work each time I got the shot". Relevant laboratory tests and procedures are available in the appropriate section. The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if and when received. Sender's Comments: Linked Report(s) : US-PFIZER INC-202201056719 same patient, different product and event; PFIZER INC-202201056718 same patient and product, different dose; PFIZER INC-202201056342 same patient, different product and event; PFIZER INC-202201056967 same patient, different doses and events;
Ankle started to hurt; It went into his leg a little bit; hurt to walk on; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Ankle started to hurt), PAIN IN EXTREMITY (It went into his leg a little bit) and GAIT DISTURBANCE (hurt to walk on) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included Gout. Concomitant products included METFORMIN, GLIMEPIRIDE and RIVAROXABAN (XARELTO).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Ankle started to hurt), PAIN IN EXTREMITY (It went into his leg a little bit) and GAIT DISTURBANCE (hurt to walk on). Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 01-Feb-2021: No specific follow-up information recorded.
Expired vaccine administered to patient; Vaccines administered after being in stored in fridge past 30 days; Patient received Moderna Bivalent vaccine as First dose; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient), PRODUCT STORAGE ERROR (Vaccines administered after being in stored in fridge past 30 days), WRONG PRODUCT ADMINISTERED (Patient received Moderna Bivalent vaccine as First dose) and NO ADVERSE EVENT (no adverse event) in a 72-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7185B) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient), PRODUCT STORAGE ERROR (Vaccines administered after being in stored in fridge past 30 days), WRONG PRODUCT ADMINISTERED (Patient received Moderna Bivalent vaccine as First dose) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient), PRODUCT STORAGE ERROR (Vaccines administered after being in stored in fridge past 30 days), WRONG PRODUCT ADMINISTERED (Patient received Moderna Bivalent vaccine as First dose) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient), PRODUCT STORAGE ERROR (Vaccines administered after being in stored in fridge past 30 days) and WRONG PRODUCT ADMINISTERED (Patient received Moderna Bivalent vaccine as First dose).    Concomitant medication details not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-730541 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-730541:Same reporter
Headache, NauseaVomiting, SORE THROAT, FATIGUE, RESTLESSNESS Narrative:  ER; GIVEN NOTE TO STAY OFF WORK UNTIL 1-19-21
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 41 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left (Lot number: EW0187) as dose 1, single and administered in arm left (Lot number: EW0187) for 1 day as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: JUNEL FE. Past drug history included: Oxycodone for Allergy, notes: Oxycodone, Albuterol; Albuterol for Allergy. The following information was reported: INTERMENSTRUAL BLEEDING (non-serious) with onset 30May2021, outcome "recovered", described as "Light spotting for a week after the first dose administration while still on the contraceptive pill. Heavier spotting after the second administered dose while still on the pill.". Therapeutic measures were not taken as a result of intermenstrual bleeding.Additional information: Vaccine was administered in Pharmacy or Drug store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient had no covid prior vaccination. The patient has not been tested for COVID-19 post vaccination.No follow-up attempts are possible. No further information is expected.
Severe Chills Lasted two days  Facial Swelling Sweating lasted 3 days Severe Fatigue Entire Body to the point of not being able to get up from bed.  Lasted two Days some less on third and fourth day Disorientation lasted two days Blisters in upper part of mouth 2 days
SEVERELY EDEMATOUS LEFT ARM.WARM TO TOUCH. MOM STATES,CONDITION NOTED 10/23/07 PM. NO ELEVATED TEMP. EXTREMITY FREELY MOBILE AND CHILD DENIES PAIN.PATIENT REFERRED TO PRIMARY CARE PROVIDER FOR FURTHER MEDICAL MANAGEMENT .
Raised, painful, erythematous pustules at injection site Medical diagnosis - shingles Rx valacyclovir 1 gm three times daily
Patient inadvertently administered 1st dose of Moderna covid 19 vaccine to person under the age of 18. Patient administered 2nd dose of Moderna covid 19 vaccine on 3/3/2021 with approval of medical director.
still feels like shit today; cold like symptoms; chills; feels hot and cold; feels hot and cold; This is a spontaneous report received from a contactable consumer (patient). This 46-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration on 15Mar2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient reported he still felt like "trash" today (as of 23Mar2021); further reporting cold like symptoms, chills, feeling hot and cold. He reported he was tested twice for COVID-19 and it was negative. He inquired if he would experience the same thing after the second dose. The clinical outcomes of feels like "trash" today, cold like symptoms, chills, feels hot and cold were unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
I did not have an adverse reaction to the vaccine. I was exposed to COVID-19 on a plane going out-of-state. I tested positive for COVID-19 on 03/14/2023. I had congestion and a lot of body aches with COVID-19. It felt like I had the flu. I contacted a provider and got a prescription for Paxlovid. I tolerated the medication, but the test was terrible. As of today, I still feel a little tired and just a little off.
mild seizure (while asleep), t104.4 ax approx 1.5 hrs p/vax; hospitalized; dx resp distress due to sz, rt ear infect; thrush infection;
Pt states he had a rash all over his back start 24AUG after receiving vaccine on 22AUG 2018. Rash spread all over back as flat red, splotchy rash. Rash began to subside within 48hrs. Pt followed up 2 days after rash subsided.
POUNDING HEART; GENERAL MALAISE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced pounding heart, and general malaise. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pounding heart and general malaise was not reported. This report was non-serious.
About 24 hours later, had high fever and nausea. For fever used ice packs on head and chewing ice; fever reduced. Nausea continued until 11pm; had some pretzels to settle stomach. Contacted pharmacist who reviewed literature and confirmed symptoms were common. Symptoms resolved completely. There were no problems after 1st dose; just expected pain at site.
Pt received anthrax vaccine on Friday 24Jul20 sometime in the afternoon after 12 pm but before 4pm. Pt then reports later that  evening  about 3-4 hours later being severely itchy and noticing a rash covering her entire torso, both arms, both legs, scalp, neck and forehead. Pt states there was no redness or swelling at the vaccine administration site.  Pt denies fever, chills, nausea, vomiting, diarrhea, headache and this ever happening in the past.  Pt was treated with IM does of 10mg  Dexamethasone in clinic and prescribed Aterax to take today. Pt will f/u tomorrow for reeval to determine if longer course of medication is needed.